Exclusive
scalehealthtech Realize your Healthcare’s Digital Transformation journey with ScaleHealthTech Learn More

Philips to Sell Emergency Care Business to Bridgefield Capital

Written by : Dr. Aishwarya Sarthe

January 30, 2025

Category Img

The move aligns with Philips' strategy to focus on areas with greater financial and operational impact.

Royal Philips has announced an agreement to sell its Emergency Care business to Bridgefield Capital, a US-based investment firm.

The move aligns with Philips' strategy to focus on areas with greater financial and operational impact.

Philips and its Emergency Care business will enter into an exclusive brand license agreement, allowing the continued use of the Philips brand for the manufacturing, sales, and marketing of Emergency Care products globally for up to 15 years.

The Emergency Care division, part of Philips' Connected Care segment, provides essential acute care solutions, including automated external defibrillators and emergency care devices used in both professional and consumer settings.

As part of its 2023 strategic realignment, Philips assessed various options for the Emergency Care unit before deciding to divest to Bridgefield Capital.

The investment firm specializes in advising and supporting businesses to enhance growth and profitability.

The transaction is subject to regulatory approval and other closing conditions, with finalization expected in the second half of 2025. Financial details of the deal have not been disclosed.


More from this Author

POPULAR CATEGORIES

WEEKLY POPULAR POSTS

ABOUT US

Digital Health News ( DHN) is India’s first dedicated digital health news platform launched by Industry recognized HealthTech Leaders. DHN Is Industry’s Leading Source Of HealthTech Business, Insights, Trends And Policy News.

DHN Provides In-Depth Data Analysis And Covers Most Impactful News As They Happen Across Entire Ecosystem Including Emerging Technology Trends And Innovations, Digital Health Startups, Hospitals, Health Insurance, Govt. Agencies & Policies, Pharmaceuticals And Biotech.

CONTACT US

© Digital Health News 2025